Abalone Bio is dedicated to developing novel gene therapies that target the underlying genetic

Abalone Bio is dedicated to developing novel gene therapies that target the underlying genetic causes of rare and serious diseases. The company’s mission is to bring hope to patients by providing innovative treatments that can significantly improve their quality of life. Abalone Bio envisions becoming a leader in the gene therapy field by advancing its proprietary technologies and delivering effective treatments for rare genetic disorders. The company aims to transform the landscape of disease treatment through its innovative approach to genetic medicine.